Evidence map›Paper›PMID 36651079›Full record

ArticleBJPsych open2023

Cognitive versus emotional modulation within a Stroop paradigm in patients with schizophrenia.

Verónica Romero-Ferreiro, Ana García-Gutiérrez, Iosune Torio, Paloma Marí-Beffa, Pablo Rodríguez-Gómez, José A Periáñez, Eva M Moreno, Carmen Romero, Miguel Ángel Alvarez-Mon, Roberto Rodriguez-Jimenez

Abstract read
In one paragraph

Article in BJPsych open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Verónica Romero-FerreiroDepartment of Psychology, Universidad Europea de Madrid, Spain; Department of Psychiatry, Instituto de Investigación Hospital 12 de Octubre (Imas12), Spain; and Biomedical Research Networking Centre for Mental Health/Carlos III Health Institute (CIBERSAM/ISCIII), Spain.ORCID https://orcid.org/0000-0003-3211-1744
Ana García-GutiérrezDepartment of Experimental Psychology, Cognitive Psychology and Speech & Language Therapy, Complutense University of Madrid, Spain.
Iosune TorioDepartment of Psychiatry, Hospital Universitario de La Princesa, Spain.
Paloma Marí-BeffaSchool of Psychology, Bangor University, Wales, UK.
Pablo Rodríguez-GómezDepartment of Psychology, Faculty of Health Sciences, Universidad Rey Juan Carlos, Spain.
José A PeriáñezDepartment of Experimental Psychology, Cognitive Psychology and Speech & Language Therapy, Complutense University of Madrid, Spain.
Eva M MorenoBiomedical Research Networking Centre for Mental Health/Carlos III Health Institute (CIBERSAM/ISCIII), Spain; Pluridisciplinar Institute, Complutense University of Madrid, Spain; and Department of Languages and Education, Universidad de Nebrija, Spain.
Carmen RomeroScientific Support Unit, Instituto de Investigación Hospital 12 de Octubre (Imas12), Spain; Biomedical Research Networking Centre for Epidemiology and Public Health/Carlos III Health Institute (CIBERESP/ISCIII), Spain; and Faculty of Health Sciences, Universidad Francisco de Vitoria, Spain.
Miguel Ángel Alvarez-MonDepartment of Medicine and Medical Specialities, Faculty of Medicine and Health Sciences, University of Alcalá, Spain; Department of Psychiatry and Mental Health, Hospital Universitario Infanta Leonor, Spain; Ramón y Cajal Institute of Sanitary Research (IRYCIS), Spain.
Roberto Rodriguez-JimenezDepartment of Psychiatry, Instituto de Investigación Hospital 12 de Octubre (Imas12), Spain; Legal Medicine, Psychiatry and Pathology, Biomedical Research Networking Centre for Mental Health/Carlos III Health Institute (CIBERSAM/ISCIII), Spain; and Legal Medicine, Psychiatry and Pathology, Complutense University of Madrid, Spain.

Funding

Comunidad de Madrid AGES-CM 2-CMInstituto de Salud Carlos III PI16/00359Instituto de Salud Carlos III PI19/00766Ministerio de Ciencia e Innovación PSI2018-098876-B-100
6 · The paper itself

Abstract

backgroundSchizophrenia is a complex disorder involving deficits in both cognitive and emotional processes. Specifically, a marked deficit in cognitive control has been found, which seems to increase when dealing with emotional information.

aimsWith the aim of exploring the possible common links behind cognitive and emotional deficits, two versions of the emotional Stroop task were administered.

methodIn the cognitive-emotional task, participants had to name the ink colour (while ignoring the meaning) of emotional words. In contrast, the emotional-emotional task consisted of emotional words superimposed on emotional faces, and the participants had to indicate the emotional valence of the faces. Fifty-eight participants (29 in-patients diagnosed with schizophrenia and 29 controls) took part in the study.

resultsPatients and controls showed similar response times in the cognitive-emotional task; however, patients were significantly slower than controls in the emotional-emotional task. This result supports the idea that patients show a more pronounced impairment in conflict modulation with emotional content. Besides, no significant correlations between the tasks and positive or negative symptoms were found. This would indicate that deficits are relatively independent of the clinical status of patients. However, a significant correlation between the emotional-emotional task and cognitive symptoms was found.

conclusionsThese findings suggest a restricted capacity of patients with schizophrenia to deal with the attentional demands arising from emotional stimuli.

Indexed as

cognitive controlconflict modulationemotionSchizophreniaStroop task

Identifiers

PMID36651079
PMCPMC9885332

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.